Oxytocin Modulation of Neural Circuit Function and Behavior
Project Number2U19NS107616-06
Former Number3U19NS107616-05W1
Contact PI/Project LeaderTSIEN, RICHARD W
Awardee OrganizationNEW YORK UNIVERSITY SCHOOL OF MEDICINE
Description
Abstract Text
Project Summary
Oxytocin is a peptide hormone synthesized and released from the hypothalamus for reproduction, maternal care,
and social behavior, as well as various ‘non-social’ aspects of internal state and physiological processes.
Although sometimes referred to as a ‘trust’ hormone, a growing body of evidence across species and brain areas
indicates that oxytocin can increase social salience, i.e., amplifying or enabling selective attention towards
certain social stimuli, such as the sound of a crying infant or the presence of a threatening or high-status
individual. Oxytocin is believed to have therapeutic potential, and delivery of oxytocin into the central nervous
system promises to improve social deficits in various mental disorders, such as autism. Despite the enthusiasm
for oxytocin, contradictory results in the efficacy of oxytocin in improving human social behaviors have been
reported. Such inconsistency in literature is likely due to our poor understanding of complexity of oxytocin action,
which likely varies with behavioral state, experience and brain structures. We believe that a better understanding
of the endogenous action of oxytocin is the key to unleash the therapeutic potential of this highly evolutionary
conserved neuropeptide. Advancing our understanding requires cross-level and comparative inter-disciplinary
studies by an group of investigators with overlapping interests and the technical capability to analyze oxytocin
signaling across molecular, physiological, systems behavioral and levels. This includes multi-animal interactions,
as many mental disorders are impactful on social behavior, over the lifespan and throughout the brain.
To these ends, this proposed U19 at NYU Grossman School of Medicine on “Oxytocin Modulation of
Neural Circuit Function and Behavior” consists of four inter-related Projects and five Core facilities, designated
by their responsibilities as Administrative, Behavior, Computational Modeling, Data Science, and Molecular Tools
Cores. The overarching goal of the four Projects and Cores is to achieve a better understanding of the oxytocin
modulation in socio-spatial behaviors through the development of new tools and theories, which we define as
social interactions within a specific context or behavioral environment. Our team will join forces to tackle the
oxytocin system from both the source (oxytocin neurons) and the receiving ends (oxytocin receptor-expressing
neurons). For Overall Aim 1, Projects 1 and 2 ask how different populations of oxytocin neurons promote stable
adult social hierarchy, extending to collective parenting to ensure the survival of offspring as one key advantage
of a stable social ecosystem. For Overall Aim 2, Project 3 dives into detailed cellular, synaptic and microcircuit
mechanisms that mediate the oxytocin actions. In Overall Aim 3, Project 4 combines knowledge and techniques
developed from Projects 1, 2, and 3 to develop methods for specific circuit perturbations to affect socio-spatial
learning over multiple spatio-temporal scales. Overall Aim 4 is to ensure that the students, postdocs, and staff
team members receive good mentoring and conduct these studies in a supportive pro-social environment.
Public Health Relevance Statement
Public Health Relevance Statement
Mental health disorders often involve disruptions of neuromodulatory systems. While oxytocin signaling has been
implicated in autism, schizophrenia and other brain disorders, we know little about where and when oxytocin is
released within the brain, or how it affects the circuits that regulate socio-spatial behaviors. Here, we take a
multidisciplinary team approach to the synaptic, neuronal and circuit effects of oxytocin and the fundamental
mechanisms by which this modulator affects parental care, adult social behavior, and cognitive function.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
121911077
UEI
M5SZJ6VHUHN8
Project Start Date
15-September-2018
Project End Date
31-July-2028
Budget Start Date
01-September-2023
Budget End Date
31-July-2024
Project Funding Information for 2023
Total Funding
$4,862,881
Direct Costs
$2,969,689
Indirect Costs
$1,893,192
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Neurological Disorders and Stroke
$4,862,881
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2U19NS107616-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2U19NS107616-06
Patents
No Patents information available for 2U19NS107616-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2U19NS107616-06
Clinical Studies
No Clinical Studies information available for 2U19NS107616-06
News and More
Related News Releases
No news release information available for 2U19NS107616-06
History
No Historical information available for 2U19NS107616-06
Similar Projects
No Similar Projects information available for 2U19NS107616-06